-
, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and the ethical, regulatory and health-economic aspects of therapy development. The network
-
biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and ethical, regulatory and health-economic aspects of therapy development
-
expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and ethical, regulatory and health-economic aspects
-
countries (HIC). The airm of this PhD project is to understand how E. coli colonization contributes tot he risk of diarrheal disease and infections with AMR and use this knowledge to design interventions
-
estimation of 3D coronary hemodynamics (velocity, pressure, and wall shear stress fields); design computational pipelines that integrate image-based anatomy, blood flow physics, and uncertainty quantification